Figure 2From: Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4Plumbagin suppresses CXCR4 expression in breast cancer cells. A, Plumbagin suppresses CXCR4 levels in a dose-dependent manner. MDA-MB-231 cells (1 × 106) were treated with the indicated concentrations of plumbagin for 6 h. Whole-cell extracts were then prepared, and 30 μg of protein was resolved on SDS-PAGE, electrotransferred onto nitrocellulose membranes, and probed for CXCR4. The same blots were stripped and reprobed with β-actin antibody to show equal protein loading. B, Plumbagin suppresses CXCR4 levels in a time-dependent manner. MDA-MB-231 cells (1 × 106) were treated with 5 μM plumbagin for the indicated times, after which Western blotting was done as described above. The same blots were stripped and reprobed with β-actin antibody to show equal protein loading. C, Plumbagin suppresses CXCR4 levels in HER2 overexpressing BT474 cells. BT474 cells (1 × 106) were treated with the indicated concentrations of plumbagin for 6 h. Whole-cell extracts were then prepared, and 30 μg of protein was resolved on SDS-PAGE, electro-transferred onto nitrocellulose membranes, and probed for CXCR4. The same blots were stripped and reprobed with β-actin antibody to show equal protein loading. D, Effect of plumbagin on HER2 expression in BT474 cells. BT474 cells (1 × 106) were treated with the indicated concentrations of plumbagin for 6 h, after which Western blotting for HER2 was done as described above. The same blots were stripped and reprobed with β-actin antibody to show equal protein loading. The representative results of three independent experiments are shown.Back to article page